REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
OTC: RVPH · CIK 0001742927 · United States
Every official REVIVA PHARMACEUTICALS HOLDINGS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RVPH filings
REVIVA PHARMACEUTICALS HOLDINGS, INC. documents
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K 2026RVPH 10-K 2026: annual report for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K 2025RVPH 10-K 2025: annual report for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K 2024RVPH 10-K 2024: annual report for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K 2023RVPH 10-K 2023: annual report for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K 2022RVPH 10-K 2022: annual report for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-Q 2026RVPH 10-Q 2026: quarterly report for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-Q 2025RVPH 10-Q 2025: quarterly report for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-Q 2024RVPH 10-Q 2024: quarterly report for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-Q 2023RVPH 10-Q 2023: quarterly report for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 10-Q 2022RVPH 10-Q 2022: quarterly report for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 8-K 2026RVPH 8-K 2026: current report for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 8-K 2025RVPH 8-K 2025: current report for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 8-K 2024RVPH 8-K 2024: current report for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 8-K 2023RVPH 8-K 2023: current report for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 8-K 2022RVPH 8-K 2022: current report for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. DEF 14A 2026RVPH DEF 14A 2026: proxy statement for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. DEF 14A 2025RVPH DEF 14A 2025: proxy statement for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. DEF 14A 2024RVPH DEF 14A 2024: proxy statement for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. DEF 14A 2023RVPH DEF 14A 2023: proxy statement for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. DEF 14A 2022RVPH DEF 14A 2022: proxy statement for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. Form 4 2026RVPH Form 4 2026: insider trading filing for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. Form 4 2025RVPH Form 4 2025: insider trading filing for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. Form 4 2024RVPH Form 4 2024: insider trading filing for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. Form 4 2023RVPH Form 4 2023: insider trading filing for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. Form 4 2022RVPH Form 4 2022: insider trading filing for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. S-1 2026RVPH S-1 2026: registration statement for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. S-1 2025RVPH S-1 2025: registration statement for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. S-1 2024RVPH S-1 2024: registration statement for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. S-1 2023RVPH S-1 2023: registration statement for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. S-1 2022RVPH S-1 2022: registration statement for fiscal 2022
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 13F 2026RVPH 13F 2026: institutional holdings for fiscal 2026
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 13F 2025RVPH 13F 2025: institutional holdings for fiscal 2025
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 13F 2024RVPH 13F 2024: institutional holdings for fiscal 2024
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 13F 2023RVPH 13F 2023: institutional holdings for fiscal 2023
- REVIVA PHARMACEUTICALS HOLDINGS, INC. 13F 2022RVPH 13F 2022: institutional holdings for fiscal 2022
More companies